The peculiar aggressiveness of luminal breast cancer in AYAs might partly be explained by AYA breast cancer genetic features, such as the common enrichment with GATA3 and ARID1A mutations (which predispose to endocrine resistance) and the lower prevalence of PIK3CA mutations (associated with better prognosis). The gene discussed is GATA3; the disease is breast carcinoma.